Illumina Files Suit Seeking Payments from Shuttered DNAPrint | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against DNAPrint Genomics and its Ellipsis Biotherapeutics subsidiary seeking payment for products Illumina shipped to the firm in 2007-2008.

According to the suit, which was filed last week in the US District Court for the Southern District of California, Illumina is seeking nearly $275,000 in payments from DNAPrint Genomics for genotyping kits and DNA analysis kits that it ordered from Illumina and didn't pay for, as stipulated under a contract between the firms in April 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.